The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder.
This approval was for treatments of SEGA that can not be treated with surgery.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm231793.htm
No comments:
Post a Comment